The Effects of Synbiotic Supplementation on Serum Anti-Inflammatory Factors in the Survivors of Breast Cancer with Lymphedema following a Low Calorie Diet: A Randomized, Double-Blind, Clinical Trial.

Autor: Saneei Totmaj A; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran., Haghighat S; Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran., Jaberzadeh S; Department of Physiotherapy, School of Primary and Allied Health Care, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Australia., Navaei M; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran., Vafa S; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran., Janani L; Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran., Emamat H; Student Research Committee, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Salehi Z; Immunology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Izad M; Immunology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Zarrati M; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Jazyk: angličtina
Zdroj: Nutrition and cancer [Nutr Cancer] 2022; Vol. 74 (3), pp. 869-881. Date of Electronic Publication: 2021 Jun 04.
DOI: 10.1080/01635581.2021.1933096
Abstrakt: Background and Aim: Breast cancer-related lymphedema (BCRL) is a treatment-related inflammatory complication in breast cancer survivors (BCSs). This study was aimed to evaluate the effect of synbiotic supplementation on serum concentrations of IL-10, TGF-β, VEGF, adiponectin, and edema volume among overweight or obese BCSs with lymphedema following a low-calorie diet (LCD).
Method: In a randomized double-blind, controlled clinical trial, 88 obese and overweight BCSs women were randomized to synbiotic supplement ( n  = 44) or placebo ( n  = 44) groups and both groups followed an LCD for 10 weeks. Pre- and post-intervention comparisons were made regarding the anti-inflammatory markers which included IL-10, TGF-β, VEGF, adiponectin, edema volume, and anthropometric measurements. Also, the same factors were analyzed to find inter-group disparities.
Results: There were no significant differences among participants in the baseline, except for IL-10 and adiponectin. Post-intervention, no significant differences were observed regarding the anti-inflammatory markers, including IL-10, VEGF, adiponectin, and TGF-β between the groups. After 10 weeks of intervention edema volume significantly decreased in the synbiotic group; additionally, anthropometric measurements (body weight, BMI, body fat percent, and WC) decreased in both groups significantly ( P  < 0.001 and P  < 0.005; respectively).
Conclusion: Synbiotic supplementation coupled with an LCD in a 10-week intervention had beneficial effects on increasing the serum TGF-β, IL-10, and adiponectin levels in women with BCRL. It also reduced arm lymphedema volume. Therefore, synbiotic supplementation can be effective in improving health status in BCRL patients.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje